|
| |
| | | 60122 | | 23.06.2010 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 06.99. | | | | 06.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Revolade 25 mg | Filmtabletten | Coated tablets (Eltrombopagum 25 mg) | B02BX05 | CI | | 02 | Revolade 50 mg | Filmtabletten | Coated tablets (Eltrombopagum 50 mg) | B02BX05 | CI | | 05 | Revolade 12,5 mg | Filmtabletten | Coated tablets (Eltrombopagum 12.5 mg) | B02BX05 | CI | | 06 | Revolade 75 mg | Filmtabletten | Coated tablets (Eltrombopagum 75 mg) | B02BX05 | CI |
|
|
|
